The role of blood component removal in essential and reactive thrombocytosis

Therapeutic Apheresis

Volumn 6, Issue 1, 2002, Pages 36-44

  Greist, Anne ^a  

^a INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

Author keywords

Essential thrombocythemia; Plateletpheresis; Reactive thrombocytosis

Indexed keywords

DRUG;

ARTICLE; BLEEDING; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HEMOLYSIS; HUMAN; INFECTION; INFLAMMATION; IRON DEFICIENCY; MALIGNANT NEOPLASTIC DISEASE; MYELOPROLIFERATIVE DISORDER; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTOPHERESIS; THROMBOCYTOSIS; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

FEMALE; HUMANS; INCIDENCE; MYELOPROLIFERATIVE DISORDERS; PLATELETPHERESIS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RISK ASSESSMENT; THROMBOCYTOSIS;

EID: 0036121401     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00394.x     Document Type: Article

References (55)

1. Hämorrhagische thrombocythämie bei vasculärer schrumfmilz
2. Hemorrhagic thrombocythemia: A critical review
3. Primary hemorrhagic thrombocythemia
4. Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group
5. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Polycythemia Vera Study Group
6. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis
7. Thrombocytosis and thrombocythemia
8. Thrombohemorrhagic complications in 101 cases of myeloproliferative disorders: Relationship to platelet number and function
9. Bleeding and thrombosis in the myeloproliferative disorders
10. Neurologic manifestations of essential thrombocythemia
11. Primary thrombocythemia
12. A single institutional experience with 43 pregnancies in essential thrombocythemia
13. Essential thrombocythemia during pregnancy
14. Essential thrombocythemia and pregnancy
15. Idiopathic thrombocythemia and pregnancy: Report of a case
16. Acquired von Willebrand disease in patients with high platelet counts
17. Recent progress in the pathogenesis and management of essential thrombocythemia
18. Occurrence, etiology, and clinical significance of extreme thrombocytosis: A study of 280 cases
19. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: Diagnostic value and correlation to complications
20. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia
21. The determination of spontaneous megakaryocyte colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thromobocytosis
22. Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis
23. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia
24. Megakaryocyte c-Mp-expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: Immunoperoxidase staining patterns and clinical correlates
25. A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications
26. Essential thrombocythemia: Another "heterogeneous disease" better understood?
27. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted County Study, 1976-1995
28. High incidence of myeloproliferative disorders in Ashkenazy Jews in northern Israel
29. Polycythemia vera and essential thrombocythemia in the elderly. Epidemiology, management and outcomes
30. Age and sex distributions of hematological malignancies in the UK
31. Major vascular complications in essential thrombocythemia: A study of the predictive factors in a series of 148 patients
32. Essential thrombocythemia in children
33. No treatment for low-risk thrombocythaemia: Results from a prospective study
34. A clinical update in polycythemia vera and essential thrombocythemia
35. Essential thrombocythemia associated with recurrent abortions and fetal growth retardation
36. Patients with essential thrombocythemia and clonal hemopoiesis detected by X-inactivation pattern are at high risk for thrombotic complications
37. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis
38. Secondary leukemia following hydroxyurea in patients with essential thrombocythemia and a high risk of thrombosis
39. Anagrelide for control of thrombocythemia in polycythemia and other myelo-proliferative disorders
40. Successful treatment of essential thrombocythemia in pregnancy with recombinant interferon-alpha 2a
41. Therapeutic apheresis in hematological and oncological diseases
42. Plateletpheresis in the management of thrombocytosis
43. Thrombocytopheresis: A rapid and effective approach to symptomatic thrombocytosis
44. Hemorrhagic thrombocythemia: Rapid platelet-pheresis by continuous flow blood cell separation
45. Therapeutic applications of continuous and intermittent flow centrifugation systems
46. Successful control of life-threatening thrombocytosis with a blood processor
47. Rapid reduction of platelet count in essential hemorrhagic thrombocythemia by discontinuous flow plateletpheresis
48. Improvement of platelet function following plateletpheresis in patients with myeloproliferative diseases
49. Control of thrombocytosis by plateletpheresis using a cell separator
50. Therapeutic thrombocytapheresis: A review of 132 patients
51. Primary thrombocythaemia in pregnancy
52. Essential thrombocythemia and coronary artery bypass surgery
53. Successful microsurgical tissue transfer in a patient with postsplenectomy thrombocytosis treated with platelet-phoresis
54. Therapeutic plateletpheresis in thrombocythemia
55. Failure of long-term platelet-pheresis to control primary thrombocytosis